🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/10/2021 | 81,64 | 81,64 | 79,87 | 79,93 | -0,87% | 2,17% | 11.279.700 |
| 08/10/2021 | 81,67 | 81,80 | 80,53 | 80,63 | -1,60% | 1,56% | 12.121.100 |
| 07/10/2021 | 81,54 | 82,67 | 81,03 | 81,94 | +1,59% | 2,01% | 14.190.500 |
| 06/10/2021 | 81,50 | 81,68 | 80,15 | 80,66 | -1,15% | 1,88% | 17.608.000 |
| 05/10/2021 | 82,78 | 83,39 | 81,30 | 81,60 | -1,81% | 2,52% | 28.977.800 |
| 04/10/2021 | 84,17 | 84,56 | 82,42 | 83,10 | +2,09% | 2,54% | 53.553.300 |
| 01/10/2021 | 81,56 | 84,34 | 80,63 | 81,40 | +8,37% | 4,55% | 102.497.300 |
| 30/09/2021 | 75,58 | 76,65 | 75,10 | 75,11 | +0,03% | 2,05% | 16.248.600 |
| 29/09/2021 | 73,61 | 75,70 | 73,58 | 75,09 | +2,41% | 2,88% | 16.054.500 |
| 28/09/2021 | 73,55 | 73,82 | 72,66 | 73,32 | -0,05% | 1,58% | 11.836.200 |
| 27/09/2021 | 73,51 | 74,27 | 73,34 | 73,36 | -0,34% | 1,27% | 8.630.600 |
| 24/09/2021 | 73,59 | 74,63 | 73,35 | 73,61 | +0,77% | 1,74% | 14.714.700 |
| 23/09/2021 | 72,68 | 74,04 | 72,57 | 73,05 | +1,40% | 2,02% | 12.813.500 |
| 22/09/2021 | 72,33 | 72,41 | 71,86 | 72,04 | +0,10% | 0,76% | 9.028.700 |
| 21/09/2021 | 72,48 | 72,68 | 71,77 | 71,97 | +0,06% | 1,26% | 11.995.900 |
| 20/09/2021 | 71,16 | 72,61 | 71,12 | 71,93 | +0,35% | 2,09% | 15.989.400 |
| 17/09/2021 | 71,19 | 72,00 | 70,89 | 71,68 | -0,40% | 1,56% | 43.406.600 |
| 16/09/2021 | 73,02 | 73,02 | 71,69 | 71,97 | -1,15% | 1,82% | 14.818.900 |
| 15/09/2021 | 72,08 | 73,15 | 71,88 | 72,81 | +0,97% | 1,76% | 12.555.900 |
| 14/09/2021 | 73,05 | 73,14 | 72,06 | 72,11 | -1,46% | 1,48% | 15.202.800 |
| 13/09/2021 | 73,77 | 73,83 | 72,86 | 73,18 | -0,37% | 1,31% | 11.245.200 |
| 10/09/2021 | 73,98 | 74,21 | 73,12 | 73,45 | -0,50% | 1,47% | 11.084.500 |
| 09/09/2021 | 75,19 | 75,19 | 73,60 | 73,82 | -2,04% | 2,11% | 14.628.700 |
| 08/09/2021 | 75,97 | 75,97 | 74,80 | 75,36 | -0,82% | 1,54% | 8.243.000 |
| 07/09/2021 | 76,59 | 76,87 | 75,17 | 75,98 | -1,66% | 2,22% | 13.979.500 |
| 03/09/2021 | 77,26 | 77,38 | 76,69 | 77,26 | +0,18% | 0,89% | 6.629.800 |
| 02/09/2021 | 76,48 | 77,14 | 76,17 | 77,12 | +1,23% | 1,27% | 6.559.400 |
| 01/09/2021 | 76,22 | 76,80 | 75,83 | 76,18 | -0,14% | 1,27% | 9.187.200 |
| 31/08/2021 | 76,79 | 77,10 | 76,03 | 76,29 | -0,27% | 1,39% | 10.949.500 |
| 30/08/2021 | 76,30 | 76,84 | 76,21 | 76,50 | +0,26% | 0,83% | 7.339.700 |